Prime Medicine, Inc. - 8-K Filing

Prime Medicine reports preliminary cash position of $61.2 million as of September 30, 2026 (Items: 2.02 Results of Operations and Financial ConditionOn November 10, 2026, Prime Medicine, Inc, 8.01 Other Events On November 10, 2026, the Company posted an updated corporate presentation to its website at https://investors, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $PRME

Read the full article at SEC EDGAR

Part of the story Cycurion, Inc. - 8-K Filing (3 articles)

More Regulatory news